Skip to main content

Table 3 The median serum SAA, CA125 and HE4 concentration

From: Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression

Group N SAA [mg/L,M (QR)] CA125 [U/L, M (QR)] HE4 [pmol/L,M (QR)]
Health 30 4.95 (3.27–7.67) 17.79 (10.48–30.77) 21.39 (14.38–30.71)
Benign disease 36 6.10 (4.70–9.45) 35.86 (15.82–53.16) 47.73 (37.39–74.64)
Ovarian cancer 36 32.30 (11.20–119.6) 640.00 (251.65–1218.50) 259.5 (125.00-
736.00)